Alterations in transforming growth factor-α and epidermal growth factor receptor expression during rat esophageal tumorigenesis

Molecular Carcinogenesis

Volumn 15, Issue 2, 1996, Pages 144-153

  Wang, Qian Shu ^a   Sabourin, Carol L K ^a   Bijur, Gautam N ^a   Robertson, Fredika M ^a   Stoner, Gary D ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Chemical carcinogenesis; Gene expression; Papilloma; Preneoplastic

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ESOPHAGUS CANCER; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PAPILLOMA; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; CARCINOGENS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DIMETHYLNITROSAMINE; DNA PRIMERS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION; IN SITU HYBRIDIZATION; MALE; MOLECULAR SEQUENCE DATA; PAPILLOMA; POLYMERASE CHAIN REACTION; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA, MESSENGER;

ANIMALIA;

EID: 0029917811     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199602)15:2<144::AID-MC7>3.0.CO;2-J     Document Type: Article

References (51)

1. Parkin DM, Stjernsward J, Muir CS Estimates of the worldwide frequency of twelve major cancers. Bull World Health Organ 62:163, 1984.
2. Wynder EL, Bross IJ. A study of etiology factors in cancer of esophagus Cancer 14.389-413, 1961.
3. Walker EA, Castegnaro M, Garren L, Toussaint G, Kowalski B. Intake of volatile nitrosamines from consumption of alcohols. J Natl Cancer Inst 63.947-951, 1979.
4. Yang CS Research on esophageal cancer in China: A review. Cancer Res 40:2633-2644, 1980
5. Warwick GP, Harington JS. Some aspects of the epidemiology and etiology of esophageal cancer with particular emphasis on the Transkei, South Africa. Adv Cancer Res 17:81-229, 1973.
6. Druckrey H Organospecific carcinogenesis in the digestive tract. In: Nakahara W, Takayama S, Sugimura T, et al. (eds), Topics in Chemical Carcinogenesis University Park Press, Baltimore, 1972, pp. 73-101
7. Wang Y, You M, Reynolds SH, Stoner GD, Anderson MW. Mutational activation of the cellular Harvey ras oncogene in rat esophageal papillomas induced by methylbenzylnitrosamine Cancer Res 50-1591-1595, 1990
8. Barch DH, Jacoby RF, Brasitus TA, Radosevich JA, Carney WP, lannaccone PM. Incidence of Harvey ras oncogene point mutations and their expression in methylbenzylnitrosamine-indueed esophageal tumongenesis. Carcinogenesis 12:2373-2377, 1991.
9. Lozano J-C, Nakazawa H, Cros M-P, Cabrai R, Yamasaki H G-A mutations in p53 and Ha-ras genes in esophageal papillomas induced by N-nitrosomethylbenzylamine in two strains of rats. Mol Carcinog 9 33-39, 1994.
10. Stoner GD, Mandal-Chaudhuri S, Daniel EM, Heur Y-H, Morrissey DT Chemoprevention of esophageal cancer by ellagic acid and phenethyl isothiocyanate In: Wattenberg LW, Lipkin M, Boone CW, Kelloff GJ (eds), Cancer Chemoprevention. CRC Press, Inc., Boca Raton, FL, 1992, pp 407-439
11. Derynck R Transforming growth factor α Cell 54-593-595, 1988.
12. Cutry AF, Kinniburgh AJ, Krabak MJ, Hui S-W, Wenner CE. Induction of c-fos and c-myc proto-oncogene expression by epidermal growth factor and transforming growth factor alpha is calcium independent. J Biol Chem 264:19700-19705, 1989
13. Imanishi K, Yamaguchi K, Honda S, Abe K. Transforming growth factor-alpha as a possible autocrine growth factor for human adenocarcinoma of the lung. In Imura H, Shizume K, Yoshida S (eds), Progress in Endocrinology, Vol. 2 Excerpta Medica, New York, 1988, pp 1363-1368.
14. Valverius EM, Bates SE, Stampfer MR, et al. Transforming growth factor alpha production and epidermal growth factor receptor expression in normal and oncogene transformed human mammary epithelial cells. Mol Endocrinol 3:203-214, 1989
15. Smith JJ, Derynck R, Korc M. Production of transforming growth factor alpha in human pancreatic cancer cells: Evidence for a superagonist autocrine cycle Proc Natl Acad Sci USA 84 7567-7570, 1987.
16. Yoshida O, Kyo E, Tsujino T, Sano T, Niimoto M, Tahara E. Expression of epidermal growth factor, transforming growth factor-alpha and their receptor genes in human gastric carcinomas: Implication for autocrine growth. Jpn J Cancer Res 81:43-51, 1990
17. Yoshida K, Kyo E, Tsuda T, et al. EGF andTGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors, Int J Cancer 45.131-135, 1990.
18. Anzano MA, Rieman D, Prichett W, Bowen-Pope DF, Greig R. Growth factor production by human colon carcinoma cell lines. Cancer Res 49:2898-2904, 1989.
19. Dominey AM, Wang X-J, King LE Jr, et al Targeted overexpression of transforming growth factor α in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas. Cell Growth Differ 4 1071-1082, 1993
20. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC. Overexpression of TGFα in transgenic mice. Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast Cell 61:1121-1135, 1990.
21. Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH, Merlino GT. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61.1137-1146, 1990.
22. Ennis BW, Valverius EM, Bates SE, et al. Anti-epidermal growth factor receptor antibodies inhibit the autocrine-stimulated growth of MDA-468 human breast cancer cells. Mol Endocrinol 3:1830-1838,1989
23. Rodeck U, Noel W, Murthy U, Herlyn M. Monoclonal antibody 425 inhibits growth stimulation of carcinoma cells by exogenous EGF and tumor-derived EGF/TGF-alpha. J Cell Biochem 44 69-79, 1990.
24. Watkins LF, Levine AE Differential role of transforming growth factor-α in two human colon carcinoma cell lines, Int J Cancer 47455-460, 1991.
25. Derynck R, Goeddel DV, Ullrich A, et al. Synthesis of messenger RNAs for transforming growth factor α and β and the epidermal growth factor receptor by human tumors Cancer Res 47:707-712, 1987
26. Gullick WJ. Prevalence of aberrant expression of the epidermal growth factor receptor in human cancers. Br Med Bull 47 87-98, 1991.
27. Glick AB, Sporn MB, Yuspa SH. Altered regulation of TGFβ1 and TGFα in primary keratinocytes and papillomas expressing v-Haras. Mol Carcinog 4:210-219, 1991.
28. Ha oncogene. Cell Growth Differ 4:317-327, 1993
29. Ciardiello F, Kim N, Hynes N, et al Induction of transforming growth factor α expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene. Mol Endocrinol 2.1202-1216, 1988.
30. Gardiello F, McGeady ML, Kim N, et al Transforming growth factor-α expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-α complementary DNA leads to transformation. Cell Growth Differ 1:407-420, 1990.
31. Theodorescu D, Cornil I, Sheehan C, Man MS, Kerbel RS. Ha-ras induction of invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells Cancer Res 51.4486-4491, 1991.
32. Rho O, Beltrán LM, Gimenez-Conti IB, DiGiovanni J Altered expression of the epidermal growth factor receptor and transforming growth factor-α during multistage skin carcinogenesis in SENCAR mice Mol Carcinog 11.19-28, 1994
33. Coffey RJ Jr, Derynck R, Wilcox JN, et al Production and autoinduction of transforming growth factor-α in human keratinocytes Nature 328.817-820, 1987.
34. Bjorge JD, Kudlow JE Epidermal growth factor receptor synthesis is stimulated by phorbol ester and epidermal growth factor. J Biol Chem 262 6615-6622, 1987
35. Yano H, Shiozaki H, Kobayashi D, et al. Immunohistologic detection of the epidermal growth factor receptor in human esophageal squamous cell carcinoma. Cancer 67:91-98, 1991,
36. Esteve A, Lehman T, Jiang W, et al Correlation of p53 mutations with epidermal growth factor receptor overexpression and absence of mdm2 amplification in human esophageal carcinomas. Mol Carcinog 8:306-311, 1993.
37. Jankowski J, McMennemin R, Hopwood D, Penston JG, Wormsley KG Abnormal expression of growth regulatory peptides in Barrett's esophagus Clin Sci 81:663-668, 1991.
38. Al-Kasspooles M, Moore JH, Orringer MB, Beer DG. Amplification and overexpression of the EGFR and erbB-2 genes in human esophageal adenocaronomas Int J Cancer 54:213-219, 1993.
39. Jankowski J, McMenemin R, Yu C, Hopwood D, Wormsley KG. Proliferating cell nuclear antigen in esophageal diseases: Correlation with transforming growth factor alpha expression. Gut 33-587-591, 1992
40. Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer Cancer Res 533579-3584, 1993.
41. Shin DM, Ro JY, Hong WK, Hittelman WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 54:3153-3159, 1994
42. Sardelli S. Amplifications: A Forum for PCR Users, Vol 9. Perkin-Elmer Cetus, Norwalk, CT, 1993, pp. 3-5.
43. Kaser MR, Lakshmanan J, Fisher DA Comparison between epidermal growth factor, transforming growth factor-α, and EGF receptor levels in regions of adult rat brain Mol Brain Res 16-316-322, 1992
44. Blasband AJ, Rogers KT, Chen X, Azizkhan JC, Lee DC. Characterization of the rat transforming growth factor alpha gene and identification of promoter sequences. Mol Cell Biol 10.2111-2121, 1990.
45. Petch LA, Harris J, Raymond VW, Blasband AJ, Lee DC, Earp HS. A truncated, secreted form of the epidermal growth factor receptor is encoded by an alternatively spliced transcript in normal rat tissue. Mol Cell Biol 10:2973-2982, 1990
46. Jansen JG, Vneling H, van Zeeland AA, Mohn GR. The gene encoding hypoxanthine-guanine phosphoribosyltransferase as target for mutational analysis: PCR cloning and sequencing of the cDNA from the rat. Mutat Res 266 105-116, 1992.
47. Lane KB, Zoia O, Davidson JM Semi-dry electrophoretic transfer of RNA to membranes BioTechniques 12.340-342, 1992.
48. Logel J, Dill D, Leonard S Synthesis of cRNA probes from PCR-generated DNA. BioTechniques 13 604-610, 1992.
49. Sporn MB, Todaro GJ. Autocrine secretion and malignant transformation of cells. N Engl J Med 303-878-880, 1980
50. Jhappan C, Takayama H, Dickson RB, Merlino G Transgenic mice provide genetic evidence that transforming growth factor α promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways. Cell Growth Differ 5.385-394, 1994.
51. Wang X-J, Greenhalgh DA, Eckhardt JN, Rothnagel JA, Roop DR Epidermal expression of transforming growth factor-α in transgemc mice: Induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression Mol Carcinog 10 15-22, 1994